Khalil Katato

413 total citations
18 papers, 172 citations indexed

About

Khalil Katato is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khalil Katato has authored 18 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khalil Katato's work include Renal cell carcinoma treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Khalil Katato is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Khalil Katato collaborates with scholars based in United States, Jordan and Lebanon. Khalil Katato's co-authors include Nathan R. Wall, Ramzi M. Mohammad, Ayad Al‐Katib, Mahmoud Barbarawi, Ghassan Bachuwa, Yazan Zayed, Babikir Kheiri, Frances W.J. Beck, Adam Chahine and Nayera Hamdy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Gastroenterology.

In The Last Decade

Khalil Katato

15 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalil Katato United States 6 63 49 35 33 31 18 172
Maria DeMol Switzerland 4 68 1.1× 26 0.5× 11 0.3× 19 0.6× 42 1.4× 4 318
Peishu Liu China 13 77 1.2× 10 0.2× 15 0.4× 33 1.0× 16 0.5× 18 303
Pilar Antón Spain 5 109 1.7× 22 0.4× 8 0.2× 38 1.2× 19 0.6× 9 180
Xuliang Shen China 8 105 1.7× 15 0.3× 6 0.2× 42 1.3× 11 0.4× 23 184
Daniela Etro Italy 6 106 1.7× 57 1.2× 5 0.1× 26 0.8× 8 0.3× 10 394
D. Gailani United States 6 43 0.7× 169 3.4× 26 0.7× 5 0.2× 30 1.0× 6 309
T. Navin United Kingdom 5 107 1.7× 7 0.1× 15 0.4× 38 1.2× 28 0.9× 6 339
Monica Piedimonte Italy 5 46 0.7× 22 0.4× 5 0.1× 15 0.5× 8 0.3× 6 137
Moataz Ellithi United States 7 21 0.3× 35 0.7× 3 0.1× 69 2.1× 18 0.6× 25 153
Qinghui Niu China 12 210 3.3× 10 0.2× 7 0.2× 37 1.1× 24 0.8× 27 365

Countries citing papers authored by Khalil Katato

Since Specialization
Citations

This map shows the geographic impact of Khalil Katato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Katato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Katato more than expected).

Fields of papers citing papers by Khalil Katato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Katato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Katato. The network helps show where Khalil Katato may publish in the future.

Co-authorship network of co-authors of Khalil Katato

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Katato. A scholar is included among the top collaborators of Khalil Katato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Katato. Khalil Katato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Katato, Khalil, et al.. (2022). S2066 Leptomeningeal Carcinomatosis in Metastatic Colorectal Adenocarcinoma. The American Journal of Gastroenterology. 117(10S). e1411–e1411.
2.
Xu, Huiwen, Supriya G. Mohile, Marie Flannery, et al.. (2020). Using machine learning to identify older adults at high risk for hospitalization and mortality via the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).. Journal of Clinical Oncology. 38(29_suppl). 169–169. 3 indexed citations
3.
Haykal, Tarek, et al.. (2020). Does chemotherapy affect survival of breast cancer (BC) patients with recurrence score 26-30?. Journal of Clinical Oncology. 38(15_suppl). 523–523. 2 indexed citations
4.
Katato, Khalil, et al.. (2020). The role of cytoreductive nephrectomy in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 38(15_suppl). e17080–e17080. 2 indexed citations
5.
Barbarawi, Mahmoud, Yazan Zayed, Babikir Kheiri, et al.. (2019). The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials. Thrombosis Research. 181. 36–45. 11 indexed citations
6.
Haykal, Tarek, Babikir Kheiri, Yazan Zayed, et al.. (2019). Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials. Journal of Orthopaedics. 16(4). 294–302. 25 indexed citations
7.
Haykal, Tarek, Mahmoud Barbarawi, Yazan Zayed, et al.. (2019). Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials. Journal of Cancer Research and Clinical Oncology. 145(7). 1795–1809. 20 indexed citations
8.
Katato, Khalil, et al.. (2018). The Effect of Perioperative Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative Breast Cancer: A Meta-Analysis. Breast Cancer Basic and Clinical Research. 12. 2220349754–2220349754. 5 indexed citations
9.
Haykal, Tarek, Babikir Kheiri, Mahmoud Barbarawi, et al.. (2018). Aspirin Use in Venous Thromboembolism Prophylaxis Following Hip or Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials. Blood. 132(Supplement 1). 1240–1240. 1 indexed citations
10.
Ghamrawi, Ranine, et al.. (2017). Factors associated with short recurrence-free survival in completely resected colon cancer. Journal of Community Hospital Internal Medicine Perspectives. 7(6). 341–346. 3 indexed citations
11.
Shaik, Mohammed, et al.. (2013). Survival rates of male breast cancer compared to female: A Surveillance, Epidemiology, and End Results (SEER) database analysis.. Journal of Clinical Oncology. 31(15_suppl). 6567–6567.
12.
Tesfaye, Anteneh, et al.. (2012). Prognostic significance of degree of anemia in renal cell carcinoma.. Journal of Clinical Oncology. 30(5_suppl). 469–469. 3 indexed citations
13.
Tesfaye, Anteneh, et al.. (2012). Does obesity affect the outcome of renal cell carcinoma?. Journal of Clinical Oncology. 30(5_suppl). 444–444.
14.
Katato, Khalil, et al.. (2011). The effect of statins on overall survival of breast cancer.. Journal of Clinical Oncology. 29(27_suppl). 34–34. 2 indexed citations
15.
Singh, Anoop, et al.. (2010). Incidence of second malignancies among 10,919 patients over 20 years: Retrospective analysis of a community hospital cancer registry data.. Journal of Clinical Oncology. 28(15_suppl). e12026–e12026. 1 indexed citations
16.
Mohammad, Ramzi M., Frances W.J. Beck, Khalil Katato, et al.. (1998). Potentiation of 2-Chlorodeoxyadenosine Activity by Bryostatin 1 in the Resistant Chronic Lymphocytic Leukemia Cell Line (WSU-CLL): Association with Increased Ratios of dCK/5'-NT and Bax/Bcl-2. Biological Chemistry. 379(10). 1253–1262. 27 indexed citations
17.
Mohammad, Ramzi M., Khalil Katato, Nathan R. Wall, et al.. (1998). Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.. PubMed. 4(2). 445–53. 32 indexed citations
18.
Mohammad, Ramzi M., et al.. (1996). Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.. PubMed. 10(1). 130–7. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria DeMol Breakdown of academic impact, for papers by Peishu Liu Breakdown of academic impact, for papers by Pilar Antón Breakdown of academic impact, for papers by Xuliang Shen Breakdown of academic impact, for papers by Daniela Etro Breakdown of academic impact, for papers by D. Gailani Breakdown of academic impact, for papers by T. Navin Breakdown of academic impact, for papers by Monica Piedimonte Breakdown of academic impact, for papers by Moataz Ellithi Breakdown of academic impact, for papers by Qinghui Niu
Rankless by CCL
2026